SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-321155
Filing Date
2019-12-20
Accepted
2019-12-20 17:23:23
Documents
7
Period of Report
2019-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831361d8k.htm 8-K 29541
2 EX-4.1 d831361dex41.htm EX-4.1 98530
3 EX-4.2 d831361dex42.htm EX-4.2 74455
4 EX-10.1 d831361dex101.htm EX-10.1 180205
5 EX-10.2 d831361dex102.htm EX-10.2 131641
6 EX-99.1 d831361dex991.htm EX-99.1 12233
7 GRAPHIC g831361g13f61.jpg GRAPHIC 12368
  Complete submission text file 0001193125-19-321155.txt   545487
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 191302729
SIC: 2834 Pharmaceutical Preparations